Alaunos Therapeutics, Inc. (TCRT) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 970K | 1.99M | 2.69M | 3.74M | 1.07M | 2.75M | 3.55M | 4.68M | 6.04M | 8.26M | 12.87M | 18.78M | 38.18M | 53.8M | 55.51M | 61.36M | 69.77M | 78.83M | 96.55M | 89.41M |
| Cash & Short-Term Investments | 354K | 1.39M | 1.94M | 2.88M | 319K | 1.09M | 1.68M | 2.46M | 4.14M | 6.06M | 11.94M | 18.32M | 23.5M | 39.06M | 37.81M | 60.01M | 68.25M | 76.05M | 91.72M | 76.75M |
| Cash Only | 354K | 1.39M | 1.94M | 2.88M | 319K | 1.09M | 1.68M | 2.46M | 4.14M | 6.06M | 11.94M | 18.32M | 23.5M | 39.06M | 37.81M | 60.01M | 68.25M | 76.05M | 91.72M | 76.75M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 3K | 0 | 2K | 2K | 5K | 0 | 4K | 1K | 1K | 0 | 4K | 0 | 4K | 2.91M | 0 | 0 | 1.11M | 1.51M | 0 |
| Days Sales Outstanding | - | 92 | - | - | 157.5 | 115 | - | 56.88 | 91 | 92 | - | 91 | - | 12.19K | 92 | - | - | - | 349.05 | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.94M | 0 | -1.11M | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | 412.71 | - | - | - | - | - | - |
| Other Current Assets | 616K | 600K | 747K | 857K | 746K | 1.66M | 1.87M | 2.21M | 1.89M | 2.2M | 925K | 457K | 14.69M | 799K | 13.94M | 1.35M | 1.52M | 1.67M | 3.32M | 9.43M |
| Total Non-Current Assets | 913K | 978K | 1.04M | 997K | 1.05M | 0 | 0 | 0 | 0 | 2K | 6.57M | 9.15M | 10.45M | 11.14M | 11.84M | 12.57M | 15.22M | 16.03M | 17.21M | 17.36M |
| Property, Plant & Equipment | 82K | 91K | 97K | 0 | 0 | 0 | 0 | 0 | 0 | 2K | 6.57M | 8.65M | 9.91M | 10.6M | 11.3M | 12.03M | 14.55M | 15.36M | 16.84M | 16.98M |
| Fixed Asset Turnover | - | 0.03x | - | - | - | - | - | - | - | 0.00x | - | 0.00x | - | 0.00x | 0.25x | - | - | - | 0.02x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 831K | 887K | 942K | 997K | 1.05M | 0 | 0 | 0 | 0 | 0 | 0 | 501K | 542K | 542K | 542K | 542K | 668K | 673K | 367K | 381K |
| Total Assets | 1.88M | 2.97M | 3.72M | 4.74M | 2.12M | 2.75M | 3.55M | 4.68M | 6.04M | 8.26M | 19.44M | 27.93M | 48.64M | 64.94M | 67.34M | 73.93M | 84.99M | 94.86M | 113.76M | 106.77M |
| Asset Turnover | - | 0.00x | - | - | 0.00x | 0.00x | - | 0.00x | 0.00x | 0.00x | - | 0.00x | - | 0.00x | 0.04x | - | - | - | 0.00x | - |
| Asset Growth % | -11.18% | 7.66% | 4.9% | 1.22% | -64.88% | -66.66% | -81.74% | -83.25% | -87.59% | -87.28% | -71.13% | -62.23% | -42.77% | -31.55% | -40.8% | -30.75% | -33.84% | -35.18% | -31.42% | -41.23% |
| Total Current Liabilities | 595K | 813K | 921K | 1.07M | 1.06M | 692K | 826K | 907K | 1.24M | 1.96M | 4.68M | 5.05M | 17.06M | 24.17M | 32.87M | 26.77M | 21.23M | 16.04M | 28.17M | 13.59M |
| Accounts Payable | 400K | 613K | 843K | 809K | 831K | 516K | 458K | 365K | 597K | 616K | 1.3M | 1.48M | 1.38M | 1.39M | 1.98M | 474K | 605K | 1.37M | 1.46M | 982K |
| Days Payables Outstanding | 5.7K | - | - | 403.35 | - | - | - | 243.17 | 27.6K | 94.37 | 120.06 | 25.08 | 179.03 | 49.94 | 163.63 | 71.67 | 128.86 | 184.72 | - | 346.58 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.56M | 17.32M | 23.21M | 20.58M | 14.74M | 8.6M | 12.75M | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 195K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.3M | 0 | 0 | -575K | 3.74M | -542K | -525K | -745K | 3.65M | -710K | 0 |
| Current Ratio | 1.63x | 2.45x | 2.92x | 3.48x | 1.00x | 3.98x | 4.30x | 5.16x | 4.87x | 4.22x | 2.75x | 3.72x | 2.24x | 2.23x | 1.69x | 2.29x | 3.29x | 4.91x | 3.43x | 6.58x |
| Quick Ratio | 1.63x | 2.45x | 2.92x | 3.48x | 1.00x | 3.98x | 4.30x | 5.16x | 4.87x | 4.22x | 2.75x | 3.72x | 2.24x | 1.65x | 1.69x | 2.33x | 3.29x | 4.91x | 3.43x | 6.58x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | 12.55K | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 864K | 1.23M | 2.07M | 2.22M | 2.36M | 6.98M | 14.63M | 20.77M | 16.88M | 4.89M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.47M | 10.32M | 16.25M | 12.17M | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 864K | 1.23M | 2.04M | 2.19M | 2.33M | 2.48M | 4.31M | 4.52M | 4.71M | 4.89M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28K | 28K | 28K | 28K | 0 | -1K | 0 | 0 |
| Total Liabilities | 595K | 813K | 921K | 1.07M | 1.06M | 692K | 826K | 907K | 1.24M | 1.96M | 5.54M | 6.28M | 19.13M | 26.38M | 35.23M | 33.75M | 35.87M | 36.81M | 45.05M | 18.48M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.17M | 1.56M | 14.18M | 20.07M | 26.09M | 28.05M | 30.12M | 30.09M | 30.34M | 5.66M |
| Net Debt | -354K | -1.39M | -1.94M | -2.88M | -319K | -1.09M | -1.68M | -2.46M | -4.14M | -6.06M | -10.77M | -16.75M | -9.32M | -18.99M | -11.72M | -31.96M | -38.14M | -45.96M | -61.39M | -71.09M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | 0.08x | 0.07x | 0.48x | 0.52x | 0.81x | 0.70x | 0.61x | 0.52x | 0.44x | 0.06x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | -7.70x | -10.78x | -6.78x | -9.52x | -12.42x | -13.33x | -14.98x | -50.20x | -731.29x |
| Total Equity | 1.29M | 2.15M | 2.8M | 3.66M | 1.06M | 2.06M | 2.72M | 3.77M | 4.8M | 6.31M | 13.9M | 21.65M | 29.51M | 38.55M | 32.11M | 40.18M | 49.12M | 58.06M | 68.71M | 88.28M |
| Equity Growth % | 21.74% | 4.36% | 2.9% | -2.92% | -77.94% | -67.29% | -80.4% | -82.58% | -83.74% | -83.64% | -56.72% | -46.12% | -39.93% | -33.59% | -53.26% | -54.49% | -53.5% | -53.17% | -52.59% | -45.98% |
| Book Value per Share | 0.66 | 1.11 | 1.28 | 2.18 | 0.66 | 1.29 | 1.70 | 2.36 | 3.00 | 3.94 | 8.69 | 13.54 | 18.47 | 25.89 | 22.39 | 28.03 | 34.28 | 40.57 | 48.04 | 61.76 |
| Total Shareholders' Equity | 1.29M | 2.15M | 2.8M | 3.66M | 1.06M | 2.06M | 2.72M | 3.77M | 4.8M | 6.31M | 13.9M | 21.65M | 29.51M | 38.55M | 32.11M | 40.18M | 49.12M | 58.06M | 68.71M | 88.28M |
| Common Stock | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 16K | 16K | 241K | 241K | 241K | 240K | 216K | 216K | 216K | 216K | 216K | 216K |
| Retained Earnings | -925.63M | -924.62M | -923.73M | -922.57M | -921.52M | -920.45M | -919.7M | -918.58M | -917.45M | -915.77M | -907.92M | -899.45M | -890.67M | -880.63M | -871.47M | -862.57M | -852.64M | -842.85M | -831.06M | -808.33M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |